Pretransplant intervention: Pretransplant inhibition of STAT3 in graft T cells through upstream pharmacological JAK2 inhibition reduced graft-versus-host disease (GVHD) mortality and increased the levels of Tregs (116). The gene discussed is STAT3; the disease is graft versus host disease.